FDAnews
www.fdanews.com/articles/145564-j-38-j-must-pay-1-1-billion-penalty-in-arkansas-risperdal-case

J&J Must Pay $1.1 Billion Penalty in Arkansas Risperdal Case

April 11, 2012
Johnson & Johnson (J&J) was told to pay $1.1 billion by a state judge after an Arkansas jury found the company’s officials misled doctors and patients about the risks of the antipsychotic drug Risperdal.
Businessweek